These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5603841)

  • 1. [Clinical experience on Desacetyl-lanatoside C].
    Fimiani R; Silvestroni A
    Minerva Cardioangiol; 1967 Mar; 15(5):353-7. PubMed ID: 5603841
    [No Abstract]   [Full Text] [Related]  

  • 2. [The bradycardiac effect of oral administration of an overload of desacetyl-lanatoside C].
    Pavesi V; Bianchi G
    Minerva Med; 1966 Jun; 57(45):2075-8. PubMed ID: 5939220
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with desacetyl-lanatoside C in treatment and in preparation for surgery of surgical heart disease patients].
    Stocco M; Grasso A
    Minerva Chir; 1965 Sep; 20(17):757-64. PubMed ID: 5852632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of a new cardiotonic drug, desacetyl-lanatoside C].
    Warembourg H; Bertrand ME; Ducloux G
    Lille Med; 1972 Feb; 17():Suppl 2:169-72. PubMed ID: 5034397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Desacetyl-lanatoside-C in heart diseases].
    Apparete F; Pugliese F
    Minerva Cardioangiol; 1965 Oct; 13(10):692-6. PubMed ID: 5854401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biometric study of the changes of the mechanical phases of the cardiac cycle induced by intravenous desacetyl-lanatoside C in normal humans].
    Sala G; Rocca E; Riva D; Foresti A
    Minerva Cardioangiol; 1967 Jun; 15(6):424-9. PubMed ID: 6056088
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the use of desacetyl-lanatoside C in therapy of uncompensated heart diseases. Clinical contribution].
    Vercillo L; Rossi C; Vergallo L
    Minerva Med; 1965 Sep; 56(74):3172-5. PubMed ID: 5319422
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of the maintenance dosage on urinary elimination of an average standard digitalization dose of tritiated desacetyl-lanatoside C in normal subjects and in fibrillating cardiopathic subjects].
    Damascelli B; Roncoroni L; Cova N; Pavesi V; Bianchi G
    Minerva Cardioangiol; 1967 Jun; 15(6):398-403. PubMed ID: 6056084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with desacetyl-lanatoside-C].
    De Lutterotti A
    Clin Ter; 1965 Aug; 34(4):300-7. PubMed ID: 5321635
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with desglucolanatoside-C (alpha-acetyldigitoxin)].
    Reutter FW; Mazzoni S
    Praxis; 1968 Oct; 57(42):1467-70. PubMed ID: 5756698
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmatic concentrations of tritiated desacetyl-lanatoside C after intravenous and intramuscular injections in cardiopathic subjects].
    Foresti A; Damascelli B; Formentini A; Riva D
    Atti Soc Ital Cardiol; 1968; 2():211-3. PubMed ID: 4887456
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation, by the polygraphic method, of the effect of proscillaridine A and desacetyl-lanatoside C in normal subjects].
    Jacono A; De Divitiis O; Vitale P; Giordano F
    Minerva Cardioangiol; 1967 Sep; 15(9):570-8. PubMed ID: 5629534
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of the inotropic effect of lanatoside C on the cardiac function and mechanism of mitral valve closure in patients with sinus rhythm].
    Lorente P; Bourthoumeiux A; Skoufas P; Motte G; Pernot PG
    Arch Mal Coeur Vaiss; 1970 May; 63(5):720-39. PubMed ID: 4989373
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of cardiac insufficiency with lanatigen C].
    Tomov L; Orbetsov M; Tomov I; Todorova M; Visheva N
    Vutr Boles; 1979; 18(3):181-90. PubMed ID: 475894
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diacetyl-lanatoside C in the therapy of cardio-circulatory decompensation in the aged].
    Franzini C; Turri C; Bernascone E
    G Gerontol; 1965 Dec; 13(12):1441-88. PubMed ID: 5880983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a new digitalic drug: desacetyl-lanatoside C].
    Faivre G; Djaidane A
    Therapeutique; 1972 Feb; 48(2):111-5. PubMed ID: 5049320
    [No Abstract]   [Full Text] [Related]  

  • 17. [On some immediate effects of the intravenous administration of desacetyl-lanatoside C in aged subjects].
    Tàmmaro AE; Baldoli C
    Clin Ter; 1967 Jan; 40(2):157-61. PubMed ID: 5600177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of a new digitalic drug in 50 patients: deacetyl lanatoside C].
    Arnaud JC; Rocache M
    Ann Cardiol Angeiol (Paris); 1972 Oct; 21(5):493-5. PubMed ID: 4658163
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the advantages of the use of desacetyl-lanatoside C in cardiokinetic therapy].
    De Magistris L; Menegazzo G
    Minerva Med; 1967 Feb; 58(13):482-8. PubMed ID: 6021619
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL EXPERIENCE WITH A NEW CARDIOACTIVE GLYCOSIDE: DESACETYL-LANATOSIDE C].
    BOSISIO P
    Clin Ter; 1964 Mar; 28():544-61. PubMed ID: 14142763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.